ERBB2 and breast carcinoma: Prognostic factors and predictive factors such as age of the patient, involvement of axillary lymph nodes, grading, hormonal receptors, Ki67, HER2, and intratumoral lymphocytes, stratify breast cancer patients, in general, into low, intermediate, and high risk, helping to estimate prognosis and predict response to treatments (Table 1).